p63 establishes epithelial enhancers at critical craniofacial development genes-Reference-Cited by-同舟云学术

p63 establishes epithelial enhancers at critical craniofacial development genes

Published:2019-05-03 Issue:5 Volume:5 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Lin-Shiao Enrique¹²^ORCID,Lan Yemin¹,Welzenbach Julia³^ORCID,Alexander Katherine A.¹,Zhang Zhen¹,Knapp Michael⁴,Mangold Elisabeth³^ORCID,Sammons Morgan¹^ORCID,Ludwig Kerstin U.³^ORCID,Berger Shelley L.¹^ORCID

Affiliation:

1. Departments of Cell and Developmental Biology and Epigenetics Institute, Philadelphia, PA 19104, USA.

2. Biochemistry and Molecular Biophysics, Biomedical Sciences Graduate Program, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.

3. Institute of Human Genetics, University Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany.

4. Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany.

Abstract

Enhancers at critical craniofacial development genes are established by p63 and enriched for SNPs associated with CL/P.

Funder

National Cancer Institute

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference80 articles.

1. p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities